Prospective evaluation of serum alkaline phosphatase variability and prognostic utility in primary sclerosing cholangitis using controlled clinical trial data

被引:2
|
作者
Trivedi, Palak [1 ,2 ,3 ,4 ,5 ]
Muir, Andrew [6 ]
Levy, Cynthia [7 ]
Bowlus, Christopher [8 ]
Manns, Michael P. [9 ]
Lu, Xiaomin [10 ]
Crans, Gerald [10 ]
Subramanian, Mani [10 ]
Myers, Robert [10 ]
Goodman, Zachary [11 ]
Chalasani, Naga [12 ]
Vierling, John M. [13 ]
Guha, Neil [14 ]
Hirschfield, Gideon [15 ]
机构
[1] NIHR Birmingham BRC, Birmingham, W Midlands, England
[2] Ctr Liver Res, Birmingham, W Midlands, England
[3] Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
[4] Inst Appl Hlth Res, Birmingham, W Midlands, England
[5] Univ Hosp Birmingham Queen Elizabeth, Liver Unit, Birmingham, W Midlands, England
[6] Duke Clin Res Inst, Durham, NC USA
[7] Univ Miami, Miami, FL USA
[8] Univ Calif Davis, Davis, CA 95616 USA
[9] Hannover Med Sch, Hannover, Germany
[10] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[11] Inova Fairfax Hosp, Annandale, VA USA
[12] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[13] Baylor Coll Med, Houston, TX 77030 USA
[14] Univ Nottingham, NIHR Nottingham BRC, Nottingham, England
[15] Univ Toronto, Toronto Ctr Liver Dis, Univ Hlth Network, Toronto, ON, Canada
关键词
D O I
10.1016/S0618-8278(19)30022-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PS-016
引用
收藏
页码:E12 / E13
页数:2
相关论文
共 50 条
  • [1] Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis
    Trivedi, Palak J.
    Muir, Andrew J.
    Levy, Cynthia
    Bowlus, Christopher L.
    Manns, Michael P.
    Lu, Xiaomin
    Crans, Gerald
    Chung, Chuhan
    Subramanian, G. Mani
    Myers, Robert P.
    Goodman, Zachary
    Chalasani, Naga
    Vierling, John M.
    Guha, Indra Neil
    Hirschfield, Gideon M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (06) : 1248 - 1257
  • [2] Prospective validation of serum alkaline phosphatase for the prediction of disease progression in a randomized trial of patients with primary sclerosing cholangitis
    Levy, C.
    Eksteen, B.
    Shiffman, M.
    Janssen, H.
    Montano-Loza, A.
    Ding, D.
    Jia, C.
    Mccolgan, B.
    Myers, R.
    Subramanian, M.
    McHutchison, J.
    Chapman, R.
    Manns, M.
    Goodman, Z.
    Bowlus, C.
    Muir, A.
    Hirschfield, G.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S360 - S361
  • [3] PRIMARY SCLEROSING CHOLANGITIS WITH NORMAL SERUM ALKALINE-PHOSPHATASE ACTIVITY
    BALASUBRAMANIAM, K
    WIESNER, RH
    LARUSSO, NF
    GASTROENTEROLOGY, 1988, 95 (05) : 1395 - 1398
  • [4] Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value
    de Vries, Elisabeth M. G.
    Wang, Junfeng
    Leeflang, Mariska M. G.
    Boonstra, Kirsten
    Weersma, Rinse K.
    Beuers, Ulrich H.
    Geskus, Ronald B.
    Ponsioen, Cyriel Y.
    LIVER INTERNATIONAL, 2016, 36 (12) : 1867 - 1875
  • [5] PRIMARY SCLEROSING CHOLANGITIS WITH NORMAL LEVELS OF SERUM ALKALINE-PHOSPHATASE
    WIESNER, RH
    LARUSSO, NF
    HEPATOLOGY, 1985, 5 (05) : 1053 - 1053
  • [6] The Resurgence of Serum Alkaline Phosphatase as a Surrogate Biomarker for Prognosis in Primary Sclerosing Cholangitis
    Talwalkar, Jayant A.
    Chapman, Roger W.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (07) : 847 - 849
  • [7] CAN SERUM ALKALINE-PHOSPHATASE LEVELS BE NORMAL IN PRIMARY SCLEROSING CHOLANGITIS
    BALASUBRAMANIAM, K
    WIESNER, RH
    LARUSSO, NF
    GASTROENTEROLOGY, 1987, 92 (05) : 1303 - 1303
  • [8] Persistantly normal serum alkaline phosphatase in endoscopically proven primary sclerosing cholangitis
    Robillard, KT
    Shah, AN
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S158 - S159
  • [9] Association Between Baseline Serum Alkaline Phosphatase, Normalization of Alkaline Phosphatase, and Colorectal Cancer Risk in Primary Sclerosing Cholangitis
    Ali, Ahmad H.
    Hilscher, Moira
    Stanich, Peter P.
    Carey, Elizabeth J.
    Lindor, Keith D.
    Tabibian, James H.
    GASTROENTEROLOGY, 2016, 150 (04) : S1057 - S1057
  • [10] Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis
    Tabibian, James H.
    Gossard, Andrea
    El-Youssef, Mounif
    Eaton, John E.
    Petz, Jan
    Jorgensen, Roberta
    Enders, Felicity B.
    Tabibian, Anilga
    Lindor, Keith D.
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (01) : E56 - E63